Literature DB >> 3092607

Serum lipids and apoproteins in students whose parents suffered prematurely from a myocardial infarction.

G De Backer, F Hulstaert, K De Munck, M Rosseneu, L Van Parijs, M Dramaix.   

Abstract

Lipids and apoproteins as well as other coronary risk factors were measured in offspring of patients who suffered from a myocardial infarction before the age of 50 years; the results are compared with the results of a control group matched for age and sex. Significant differences were observed in the apoprotein A1 level, in the protein/fat ratios of high- and low-density lipoproteins, and in smoking habits. In a multivariate analysis, the offspring group was found to be different from the control group in nonhigh-density lipoprotein cholesterol/apoprotein B ratio, high-density lipoprotein cholesterol/apoprotein A1 ratio, smoking habits, apoprotein A1, and apoprotein A2. By means of these variables a total of 85% of all subjects could be correctly classified. We conclude that as early as age 21 years the offspring of patients with premature coronary heart disease differ from matched control subjects in lipoprotein measurements and in smoking habits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092607     DOI: 10.1016/0002-8703(86)90510-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Cardiovascular risk factor profile in subjects with familial predisposition to myocardial infarction in Denmark.

Authors:  M Hippe; J Vestbo; A M Bjerg; K Borch-Johnsen; M Appleyard; H O Hein; P K Andersen; G Jensen; T I Sørensen
Journal:  J Epidemiol Community Health       Date:  1997-06       Impact factor: 3.710

Review 2.  Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.

Authors: 
Journal:  CMAJ       Date:  1990-06-15       Impact factor: 8.262

3.  Familial predisposition and susceptibility to the effect of other risk factors for myocardial infarction.

Authors:  M Hippe; J Vestbo; H O Hein; K Borch-Johnsen; G Jensen; T I Sørensen
Journal:  J Epidemiol Community Health       Date:  1999-05       Impact factor: 3.710

4.  Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.

Authors:  Robert F Ritchie; Glenn E Palomaki; Louis M Neveux; Thomas B Ledue; Santica Marcovina; Olga Navolotskaia
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

5.  High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

Authors:  M Barbir; D Wile; I Trayner; V R Aber; G R Thompson
Journal:  Br Heart J       Date:  1988-11

6.  Addition of a novel, protective family history category allows better profiling of cardiovascular risk and atherosclerotic burden in the general population. The Asklepios Study.

Authors:  Caroline M Van daele; Tim De Meyer; Marc L De Buyzere; Thierry C Gillebert; Simon L I J Denil; Sofie Bekaert; Julio A Chirinos; Patrick Segers; Guy G De Backer; Dirk De Bacquer; Ernst R Rietzschel
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.